Biotech's big opportunity

Reform of the US healthcare system is a high priority for President Obama's new Democrat administration. The biotech sector is coming of age, and is poised to benefit by supplying the innovation required

If he has not already got his hands full with reining in the enthusiastic foreign policy strategy of his predecessor, while engineering the rescue of the world's largest economy from the near collapse of the global financial system, President Barack Obama has to find a way of reshaping the provision of healthcare to his citizens. Forty-five million people in the United States effectively lack access to affordable healthcare – something that is perhaps difficult to comprehend for those in the UK with a National Health Service providing healthcare free at the point of access. The scale of t...